Clinical Trial Update: Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Luteinizing Hormone-Releasing Hormone agonist therapy combined with Iodine-125 implant for previously untreated prostate cancer has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Iodine-125 implant
• Luteinizing Hormone-Releasing Hormone agonist therapy

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED